Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Objective We designed this study to investigate the effects of oral L-carnitine administration on fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c) and lipid parameters in patients with diabetes mellitus type II.Patients and methods The effect of L-carnitine on FPG and lipid parameters was investigated in 22 male and 13 female type II diabetic patients; the mean age +/- s.d. was 51.3 +/- 3.7 y. The patients were randomly allocated to two groups (L-carnitine and placebo group) and 1 g of L-carnitine or of placebo was given orally three times a day for a period of 12 weeks.Results FPG in the L-carnitine group decreased significantly from 143 +/- 35 to 130 +/- 33 mg/dl (P = 0.03), and we observed a significant increase of triglycerides (TG) from 196+/-61 to 233+/-12 mg/dl (P = 0.05), of Apo A1 from 94 +/- 20 to 103 +/- 23 mg/dl (P = 0.02), and of Apo B100 from 98 +/- 18 to 108 +/- 22 mg/dl (P = 0.02) after 12 weeks of treatment. There was no significant change in LDL-C, HDL-C, HbA1C, LP(a) or total cholesterol.Conclusion L-Carnitine significantly lowers FPG but increases fasting triglyceride in type II diabetic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A limited number of small scale clinical studies have likewise reported positive outcomes of L-carnitine therapy in humans (43)(44)(45).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [45]
In the citing paper
“We found only a single report in which investigators reported that 12 weeks of carnitine supplementation decreased fasting blood glucose levels in a cohort of 35 subjects (45).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [45]
In the citing paper
“Results from a limited number of small scale studies suggest that carnitine supplementation might confer insulin sensitizing actions in glucose intolerant or diabetic humans [16,58,72].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [72]
Citations
Cites
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart.
Broderick, T. L., Quinney, H. A., & Lopaschuk, G. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50590-7 · Cited by 197
Fritz, I. B., & Marquis, N. R. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1226 · Cited by 160
L-Carnitine Improves Glucose Disposal in Type 2 Diabetic Patients
Mingrone, G., Greco, A. V., Capristo, E., Benedetti, G., Giancaterini, A., Gaetano, A. D., & Gasbarrini, G. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718830 · Cited by 143
Derosa, G., Cicero, A. F. G., Gaddi, A. V., Mugellini, A., Ciccarelli, L., & Fogari, R. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80130-3 · Cited by 128
Huang, B., Wu, P., Popov, K. M., & Harris, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1371 · Cited by 122
Uziel, G., Garavaglia, B., & Di Donato, S. (1988) · Muscle & Nerve · doi:10.1002/mus.880110708 · Cited by 118
LIPID-LOWERING EFFECT OF CARNITINE IN PATIENTS WITH TYPE-IV HYPERLIPOPROTEINqMIA
Maebashi, M., Kawamura, N., Sato, M., Imamura, A., & Yoshinaga, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92587-4 · Cited by 104
Vacha, G. M., Giorcelli, G., Siliprandi, N., & Corsi, M. (1983) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/38.4.532 · Cited by 103
Rodrigues, B., Xiang, H., & McNeill, J. H. (1988) · Diabetes · doi:10.2337/diab.37.10.1358 · Cited by 101
Research works printed but not linked: 1
- Di Donto S, Garavaglia B, Rimoldi M & Carrara F (1992): Clinical and biomedical phenotypes of carnitine deficiencies. In -Carnitine and its Role in Medicine: From Function to Therapy eds. R Ferrari, S Di Mauro, G Sherwood. London: Academic Press.
Cited by
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
Role of carnitine and its derivatives in the development and management of type 2 diabetes
Bene, J., Hadzsiev, K., & Melegh, B. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0017-1 · Cited by 186
Ringseis, R., Keller, J., & Eder, K. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0284-2 · Cited by 160
Metadata
- Authors
- Rahbar, A. R., Shakerhosseini, R., Saadat, N., Taleban, F., Pordal, A., & Gollestan, B.
- Affiliations
- Shahid Beheshti University (IR)
- Corresponding author
- Rahbar, A R
- ORCID
- Venue
- European Journal of Clinical Nutrition
- Published
- 2005-03-02
- Volume
- 59
- Issue
- 4
- Pages
- 592-596
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2006960241
- Cited by
- 92
- References
- 26
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 9 · 2018: 9 · 2017: 5 · 2016: 1 · 2015: 2 · 2014: 8 · 2013: 2 · 2012: 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- L-carnitine, type 2 diabetes, fasting blood glucose, HbA1c, triglycerides, apolipoprotein A-I, apolipoprotein B-100, lipid profile, glycemic control
- MeSH terms
- Apolipoproteins, Blood Glucose, Carnitine, Cholesterol, Diabetes Mellitus, Type 2, Double-Blind Method, Fasting, Female, Glycated Hemoglobin, Humans, Iran, Lipids, Male, Middle Aged, Time Factors, Triglycerides, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. https://app.cochat.ai/papers/10.1038/sj.ejcn.1602109
- The paper
- Rahbar, A. R., Shakerhosseini, R., Saadat, N., Taleban, F., Pordal, A., & Gollestan, B. (2005). Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. European Journal of Clinical Nutrition. https://doi.org/10.1038/sj.ejcn.1602109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.